Immune-Onc Therapeutics is a biopharmaceutical company that develops therapeutic antibodies for cancer treatment. It develops a pipeline that targets the leukocyte immunoglobulin-like receptor subfamily B (LILRB) family of immune inhibitory receptors to reverse immune suppression in tumors and to eradicate pathogenic or malignant myeloid cells in autoimmune diseases and blood cancers.